Clinical Trial Update: Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2) [Phase 3]

View source ↗

Summary

Phase 3 ROMANA 2 trial results evaluate anamorelin hydrochloride for cancer cachexia in non-small cell lung cancer; the study is completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia
• Non-small Cell Lung Cancer

Drugs mentioned

• Anamorelin HCl (anamorelin hydrochloride)

Snippet

Sponsor: Helsinn Therapeutics (U.S.), Inc | Conditions: Cachexia, Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-07-11